The National Cancer Institute (NCI) invites applications for the pursuit of industry-academic partnerships for development of biomedical imaging systems and methods that are cancer specific. Support for the exchange of scientists between industry and academia can be requested under this initiative.

The goals of this initiative are to

1) Provide grants to help establish and/or expand industry-academic partnerships for development of biomedical imaging systems and methods that are cancer specific whether or not preliminary data or a history of prior collaborations have been established;

2) Support partnerships and pilot projects that may result in commercialization of imaging technologies;

3) Target partnerships that address high-risk/high-gain research and development of new approaches for early cancer detection, diagnosis, image-guided interventions, and assessment of drug therapy.

• Release Date: July 29, 2003
• Letter of Intent Receipt Date(s): October 22, 2003; October 20, 2004
• Application Receipt Date(s): November 19, 2003; November 17, 2004
• Contact: Guoying Liu, Ph.D. (liug@mail.nih.gov) at 301-594-5220

See full description in NIH Guide: PAR-03-157

What is the R21 grant mechanism?